Benzinga's Weekend M&A Chatter

Benzinga's M&A Chatter for Friday July 24 through Sunday July 26, 2015 The following are the M&A deals, rumors and chatter circulating on Wall Street for Friday July 20, 2015:

:

Teva Pharmaceutical Industries Ltd.

is in talks to merge with Allergan PLC's

generic drug unit, according to sources as reported by the

. The Allergan unit would be spun off and combined with Teva. Teva has been attempting to acquire Mylan NV

, who in turn has been working on a deal to acquire Perrigo Co. PLC

. Teva's acquisition of the Allergan business, in a deal valued at about $45 billion, could be announced as early as Monday. Teva closed at $61.85 on Friday, a loss of 1%. Allergan closed at $308.21 Friday, a loss of 2%.

:

Allergan plc

and Naurex Inc., announced Sunday, that Allergan will acquire Naurex for $560 million in an all-cash transaction. $460 million is payable upon the closing of the acquisition and $100 million is payable by January of 2016. The deal is expected to close by the end of 2015. Allergan shares closed at $308.21 Friday, a loss of 2%.

:

Anthem, Inc.

and Cigna Corporation

announced Friday, that Anthem will acquire all outstanding shares of Cigna for $103.40 in cash and 0.5152 Anthem common shares for each Cigna common share, or approximately $188.00 per share total consideration. The deal is expected to close in H2 of 2016. Cigna closed at $145.72 Friday, a loss of 5.5%.

:

McGraw Hill Financial Inc.

, the owner of Standard & Poors Ratings Services, is close to a deal to acquire SNL Financial, according to sources as reported by

. The deal is said to be valued at more than $2 billion. Sources say the deal could be announced as early as Monday. McGraw Hill Financial closed at $105.58 on Monday, down $0.92.